Social media and predicting the future

Posted by efpia on 31/03/10

People who work in healthcare occasionally become a little insular, forgetting sometimes to take a step outside of their own sector. Likewise, those of us who work in pharmaceuticals tend to think of solutions and outcomes in pharmaceutical terms, despite the fact that – as we like to remind the wider world – they are only a small proportion of healthcare costs.

I therefore found this blogpost rather interesting as well as entertaining. It was written by Scott Adams, – author of the ‘Dilbert’ cartoon strip. He speculates on some of the other things that are changing and may change how healthcare is delivered in the future, and how difficult it is to predict the future. As an outsider, he sees developments through a different prism. Sending digital photographs from patient to clinician was not something I had thought about

This was also linked to the theme of a conference I attend this week, entitled ‘Digital Pharma Europe’. Participants were looking at how the industry’s use of Social Media was likely to take shape. The industry has realized that this is a phenomenon that will substantially change the healthcare landscape, but so far it’s not clear how. One message that I took away was that Europe is far behind the US in coming to terms with Social Media in healthcare;’ the FDA have held hearings on the topic.

In Europe – as afar as I can tell -, there are little or now guidelines on what should and should not be permitted in this space; an uncertainty exacerbated by developments such as the recent Damgaard ruling. There is a pressing need for clarity, and it may be that the industry here in Europe could consider being proactive in setting out a framework for what is, and is not, acceptable.

That said, to create effective guidelines for something which is as rapidly developing as Social Media effectively means predicting the future. Yet – as the aforementioned Scott Adams blog points out – the only thing that we can predict accurately about the future is its unpredictability…

Leave a Reply »»

*
To prove you're a person (not a spam script), type the security word shown in the picture.
Anti-Spam Image

EFPIA rss

Fostering the Health Debate in Europe more.



Recent Comment

  • Feeds

  • Archives

  • Recent Posts

  • RSS EFPIA, the voice of the research-based pharmaceutical industry in Europe

    • Press Release: EAEPC-EFPIA-GIRP-PGEU working for better Patient Safety January 26, 2012
      Read below the joint press release below on the developement of  a practical and cost-effective solution to implement the requirements of the Falsified Medicines Directive in Europe: The European Stakeholder Model (ESM) Joint Press Release EDQM 260112 (function() { var scribd = document.createElement("script"); scribd.type = "text/javascript […]
    • Study: The burden of diabetes in Europe January 25, 2012
      Currently 32 million people in the EU have diabetes, withthis figure set to grow to 38.3 million by 2030. Treating diabetes and its complications takes up between 10% and 18.5% of EU member States healthcare budgets.  According to a new study released today by London School of Economics (LSE), the rise in diabetes prevalence is driven by: Increasing obesity, […]
    • What we are reading this week: January 23, 2012
      BBC News: "Fake malaria drugs could put million at risk". The Daily Telegraph: "The battle to discover new antibiotics". World Economic Forum Blog: "Global risks 2012: What if antibiotics stopped working?" Pharma Times: "Generics market to boom as blockbuster go off-patent". Inpharm: "The work of NICE internationa […]
    • Today it is World Diabetes Day January 23, 2012
      World Diabetes Day raises global awareness of diabetes According to the International Diabetes Federation (IDF) in 2011, 366 million people have diabetes and by 2030 this will have risen to 552 million. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it pro […]
    • EFPIA supports Medicrime Convention that criminilised counterfeits January 19, 2012
      EFPIA welcomes the MEDICRIME Convention launched by the Council of Europe in December 2010 and opened for signature on 28 November 2011 at a high-level conference in Moscow. EFPIA supports the Convention’s broad definition of counterfeit medicinal products, i.e. “products where a false representation has been made as regards identity and/or source”. The Conv […]
  • Twitter

    Advertisement